Skip to content

Ernexa Therapeutics Inc.: filings

Every Ernexa Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 62 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026411100001493152-26-036424
10-Q2026-05-11fiscal Q1 202637740001493152-26-022276
10-K2026-03-13fiscal FY 2025501000001493152-26-010102
10-Q2025-11-07fiscal Q3 2025431160001493152-25-021287
10-Q2025-08-13fiscal Q2 2025451170001493152-25-011910
10-Q2025-05-07fiscal Q1 202542810001641172-25-009044
10-K2025-03-12fiscal FY 2024511050001493152-25-010051
10-Q2024-11-12fiscal Q3 2024431210001493152-24-044841
10-Q2024-08-13fiscal Q2 2024431160001493152-24-031639
10-Q2024-05-14fiscal Q1 202441860001140361-24-026010
10-K2024-03-14fiscal FY 2023501040001140361-24-013254
10-Q2023-11-13fiscal Q3 2023421200001140361-23-052742
10-Q2023-08-11fiscal Q2 2023391090001140361-23-039283
10-Q2023-05-11fiscal Q1 202340840001140361-23-024180
10-K2023-03-20fiscal FY 2022471010001140361-23-012418
10-Q2022-11-14fiscal Q3 2022401120001140361-22-041399
10-Q2022-08-11fiscal Q2 2022381060001140361-22-029251
10-Q2022-07-01fiscal Q1 202238800001140361-22-024669
10-K/A2022-07-01fiscal FY 2021481100001140361-22-024668
10-K2022-04-15fiscal FY 202148970001140361-22-014764
10-Q2021-11-12fiscal Q3 2021391050001140361-21-037674
10-Q2021-08-13fiscal Q2 2021391030001140361-21-028301
10-Q2021-05-17fiscal Q1 202141830001140361-21-017648
10-K2021-03-11fiscal FY 202046920001493152-21-005827
10-Q2020-11-13fiscal Q3 2020391030001493152-20-021342
10-Q2020-08-07fiscal Q2 2020411070001493152-20-014994
10-Q2020-05-20fiscal Q1 202039800001493152-20-009524
10-K2020-03-19fiscal FY 201950990001493152-20-004343
10-Q2019-11-01fiscal Q3 2019431140001493152-19-016324
10-Q2019-08-12fiscal Q2 2019411050001493152-19-012078
10-Q2019-05-14fiscal Q1 201941810001493152-19-007099
10-K2019-03-22fiscal FY 2018531030001493152-19-003770
10-Q2018-11-09fiscal Q3 2018411100001493152-18-015583
10-Q2018-08-06fiscal Q2 201838980001493152-18-011019
10-Q2018-05-11fiscal Q1 201838750001493152-18-006666
10-K2018-03-09fiscal FY 201746940001493152-18-003164
10-Q2017-11-08fiscal Q3 201737920001493152-17-012607
10-Q2017-08-04fiscal Q2 201736910001493152-17-008543
10-Q2017-05-04fiscal Q1 201736730001493152-17-004743
10-K2017-03-09fiscal FY 201644890001493152-17-002280
10-Q2016-11-09fiscal Q3 201635880001493152-16-014680
10-Q2016-08-04fiscal Q2 201635880001493152-16-011963
10-Q2016-05-09fiscal Q1 201635710001493152-16-009551
10-K2016-03-15fiscal FY 201540800001493152-16-008049
10-Q2015-11-09fiscal Q3 201530800001019687-15-003962
10-Q2015-08-10fiscal Q2 201530800001019687-15-003021
10-Q2015-05-08fiscal Q1 201529600001019687-15-001815
10-K2015-03-27fiscal FY 201440810001019687-15-001115
10-Q2014-11-07fiscal Q3 201430780001019687-14-004114
10-Q2014-08-14fiscal Q2 201430780001019687-14-003169
10-Q2014-05-15fiscal Q1 201428580001019687-14-001956
10-K2014-03-31fiscal FY 201337750001019687-14-001135
10-Q2013-11-14fiscal Q3 201334920001019687-13-004331
10-Q2013-08-14fiscal Q2 201330760001019687-13-003135
10-Q2013-05-13fiscal Q1 201331640001019687-13-001786
10-K2013-03-29fiscal FY 2012411020001019687-13-001065
10-Q2012-11-09fiscal Q3 201234870001019687-12-003931
10-Q2012-08-14fiscal Q2 201233820001019687-12-002787
10-Q2012-05-11fiscal Q1 201230620001019687-12-001718
10-K2012-03-30fiscal FY 201136740001019687-12-001146
10-Q2011-11-14fiscal Q3 201132860001019687-11-003500
10-Q2011-08-12fiscal Q2 201128710001019687-11-002572

Inspect the source

Entity
Ernexa Therapeutics Inc. / CIK 0000748592
Captured
2026-09-19T15:01:44.435Z
SEC response SHA-256
c12754d65dfa742127976ccd7c75bc4379d46dc7b617393cfbda0b7763329d5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000748592.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))